Abstract
735P - Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have